Key facts
- China's antimalarial drug exports to Africa nearly matched India's in the past year.
China challenges India for African antimalarial drug market
IN SHORT
China's antimalarial drug exports to Africa nearly matched India's last year, signaling a significant shift in market share. Chinese exports reached $89.3 million, while India's were $89.6 million, a stark contrast to 2021 when India's exports were nearly double China's. This competition could reshape Africa's pharmaceutical landscape.
Key Numbers
89.3 millionChina's antimalarial drug exports to Africa in the past year
89.6 millionIndia's antimalarial drug exports to Africa in the past year
62.6 millionChina's antimalarial drug exports to Africa in 2021
121 millionIndia's antimalarial drug exports to Africa in 2021
Who's Involved
China
challenging India's dominance of the African antimalarial drug market
India
long-held dominance of the African antimalarial drug market
Sol Gravitas
Indian market research company
↳ Why This Matters
The growing competition between China and India in supplying antimalarial drugs to Africa could impact drug pricing and availability for millions, potentially reshaping the continent's pharmaceutical market and its reliance on specific suppliers.